- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0827
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sclerostin Inhibition in the Management of Osteoporosis ; day:26 ; month:3 ; year:2016 ; pages:1-11
Calcified tissue international ; (26.3.2016), 1-11
- Urheber
-
Appelman-Dijkstra, Natasha M.
- Beteiligte Personen und Organisationen
-
Papapoulos, Socrates E.
SpringerLink (Online service)
- DOI
-
10.1007/s00223-016-0126-6
- URN
-
urn:nbn:de:1111-2016033027697
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Appelman-Dijkstra, Natasha M.
- Papapoulos, Socrates E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Type 2 diabetes raises serum sclerostin levels and disturbs the relation between sclerostin and bone mineral density: a call for caution with antisclerostin therapy in osteoporosis
Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis
The effect of sclerostin inhibition on bone microenvironment and breast cancer bone metastases
Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis
Sclerostin and Cardiovascular Disease
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
Mutational Analysis of Sclerostin Shows Importance of the Flexible Loop and the Cystine-Knot for Wnt-Signaling Inhibition
Early sclerostin expression explains bone formation inhibition before arthritis onset in the rat adjuvant-induced arthritis model
Copeptin und Sclerostin in schwangerschaftsassoziierten Erkrankungen
Osteoporosis Management for Shoulder Surgeons
The sclerostin-neutralizing antibody AbD09097 recognizes an epitope adjacent to sclerostin's binding site for the Wnt co-receptor LRP6
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Type 2 diabetes raises serum sclerostin levels and disturbs the relation between sclerostin and bone mineral density: a call for caution with antisclerostin therapy in osteoporosis
Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis
The effect of sclerostin inhibition on bone microenvironment and breast cancer bone metastases
Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis
Sclerostin and Cardiovascular Disease
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
Mutational Analysis of Sclerostin Shows Importance of the Flexible Loop and the Cystine-Knot for Wnt-Signaling Inhibition
Early sclerostin expression explains bone formation inhibition before arthritis onset in the rat adjuvant-induced arthritis model
Copeptin und Sclerostin in schwangerschaftsassoziierten Erkrankungen
Osteoporosis Management for Shoulder Surgeons
The sclerostin-neutralizing antibody AbD09097 recognizes an epitope adjacent to sclerostin's binding site for the Wnt co-receptor LRP6
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Type 2 diabetes raises serum sclerostin levels and disturbs the relation between sclerostin and bone mineral density: a call for caution with antisclerostin therapy in osteoporosis
Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis
The effect of sclerostin inhibition on bone microenvironment and breast cancer bone metastases
Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis
Sclerostin and Cardiovascular Disease
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
Mutational Analysis of Sclerostin Shows Importance of the Flexible Loop and the Cystine-Knot for Wnt-Signaling Inhibition
Early sclerostin expression explains bone formation inhibition before arthritis onset in the rat adjuvant-induced arthritis model
Copeptin und Sclerostin in schwangerschaftsassoziierten Erkrankungen
Osteoporosis Management for Shoulder Surgeons